ArosioG., FlocchiniP. A., PremoliS., GorgerinoF.: Bayer 1420: un nuovo anestetico non barbiturico. Minerva anest., 35: 390: 1964.
2.
ClarkeR. S. J., DundeeI. W., DowR. H.: Clinical studies of induction agents XI: the influence of some intravenous anaesthetics on the respiratory effects and sequelae of Suxamethonium. Brit. J. Anaesth., 36: 307: 1964.
3.
ClarkeR. S. J., DundeeJ. W.: Clinical studies of induction agents XII: the influence of some premedicants on the course and sequelae of propanidid anaesthesia. Brit. J. Anaesth., 37: 51: 1965.
4.
DoenikeA., GurtnerT., KuglerJ., SchellembergerA., SpiessW.: Experimentelle Untersuchungen über das Ultrakurznarkotikum Propanidid mit Serum-cholinesterasebestimmungen, E.E.G. psycodiagnostischen Tests und Kreislanfanalisen, in: HoratzK., FreyR., ZindlerM.: Die intravenose Kurznarkose mit dem neuen Propanidid (Epontol).Berlin, Springer-Verlag pag. 249, 1965.
5.
DundeeJ. W., ClarkeR. S. J.: Clinical studies of induction agents IX: a comparative study of new eugenol derivative, FBA 1420 with G 29505 and standard barbiturates. Brit. J. Anaesth., 36: 100: 1964.
6.
DundeeJ. W., KirvanM. J., ClarkeR. S. J.: Anaesthesia and premedication as factor in postoperative vomiting. Acta Anaesth. Scand.9: 199: 1965.
7.
DundeeJ. W.: Some effects of premedication on the characteristics of intravenous anaestetics. Anaesth., 20: 298: 1965.
8.
HarnikE.: A study of the biphasic ventilatory effects of propanidid. Brit. J. Anaesth., 36: 655: 1964.
9.
HowellsT. H., OdellJ. R., HarwhinsT. J., SteaneP. A.: An introduction to F.BA 1420: a new nonbarbiturate intravenous anaesthetic. Brit. J. Anaesth., 36: 295: 1964.
WirthW., HoffmeisterF.: Pharmacologiche Untersuchungen mit Propanidid, in: Horatz K., Frey R., Zindler M.: Op. cit. supra, pag. 17.
16.
ZaffiriO., VandoneA., MazzeoA.: Primi risultati sull'impiego clinico del Bayer 1420 (Epontol), nuovo anestetico endovenoso non barbiturico ad azione ultrabreve. Minerva anest., 30: 1964.